Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1633
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17721003 | METHODS OF PERFUSION CULTURING A MAMMALIAN CELL | Non-Final OA | Genzyme Corporation |
| 17629286 | REGULATABLE EXPRESSION SYSTEMS | Final Rejection | Novartis AG |
| 17740102 | TARGETED INTEGRATION AT ALPHA-GLOBIN LOCUS IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 16312973 | BIO-ELECTRIC NOSE | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 17369271 | METHODS FOR STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF EUKARYOTIC CELLS | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 19234245 | TREATMENT OF DYSTROPHINOPATHIES WITH MICRODYSTROPHIN GENE THERAPY CONSTRUCTS | Final Rejection | REGENXBIO INC. |
| 17605207 | COMPOSITIONS AND METHODS CHARACTERIZING METASTASIS | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17426566 | CELL CULTURE SUBSTRATE | Non-Final OA | DAI NIPPON PRINTING CO., LTD. |
| 17777740 | MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS | Non-Final OA | UNIVERSITÉ PARIS CITÉ |
| 17714593 | DONOR ORGAN PRESERVATION USING BOTH STATIC COLD STORAGE AND EX VIVO ORGAN PERFUSION | Final Rejection | University Health Network |
| 17422646 | USE OF MESENCHYMAL STEM CELL SHEETS FOR PREVENTING UTERINE SCAR FORMATION | Non-Final OA | University of Utah Research Foundation |
| 18042323 | DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS | Non-Final OA | FIGENE, LLC |
| 17790052 | METHODS AND COMPOSITIONS FOR BINDING IMMUNOGLOBULIN PROTEIN TARGETING | Non-Final OA | Sanford Burnham Prebys Medical Discovery Institute |
| 17755368 | METHODS FOR THE PRODUCTION OF PSILOCYBIN AND INTERMEDIATES OR SIDE PRODUCTS | Final Rejection | MIAMI UNIVERSITY |
| 17609640 | IMPROVED GENE EDITING SYSTEM | Final Rejection | Suzhou Qi Biodesign biotechnology Company Limited |
| 17776932 | METHODS OF CELL SELECTION | Non-Final OA | LONZA LTD |
| 17292107 | PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL | Non-Final OA | Neurimmune AG |
| 17292315 | PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES | Non-Final OA | CORESTEM CO.,LTD. |
| 17948862 | NOVEL CELL LINE | Final Rejection | uniQure biopharma B.V. |
| 17825179 | METHOD AND DEVICE TO PRESERVE ORGANS AND TISSUE FOR TRANSPLANTATION | Final Rejection | SoftWave Tissue Regeneration Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy